Show
Sort by
-
Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice
-
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
-
Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients
-
- Journal Article
- A1
- open access
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease